基本信息
views: 71
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Michael Hanson is the Director of Technology at the Frost Institute for Chemistry and Molecular Sciences at the University of Miami and CSO of Abilita Bio in San Diego. Dr. Hanson is a serial entrepreneur in the biotechnology space, co-founding StructureTx and serving as CTO, founding and leading the GPCR Consortium as President, and serving as Director of Structural Discovery at Receptos. Dr. Hanson played a significant role in building and implementing a "toolbox" of techniques for working with and determining structures of integral membrane proteins such as GPCRs. In addition, he has led early-stage discovery and contributed to three clinical-stage programs, including Zeposia, an approved therapy for multiple sclerosis and ulcerative colitis.
Research Interests
Papers共 95 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Natureno. 7989 (2023): E19-E19
Michael A. Hanson, Maria C. Orencia
GPCRs as Therapeutic Targetspp.299-345, (2022)
Yang Yue, Lier Liu,Li-Jie Wu,Yiran Wu,Ling Wang,Fei Li,Junlin Liu,Gye-Won Han, Bo Chen,Xi Lin,Rebecca L. Brouillette, Émile Breault,
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn